NASDAQ: BACQInflection Point Acquisition Corp IV Stock
$10.58-0.03 (-0.28%)
Updated Jan 30, 2026
BACQ Price
$10.58
Fair Value Price
N/A
Market Cap
$357.16M
52 Week Low
$9.91
52 Week High
$13.21
P/E
N/A
P/B
-33.92x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.13
Operating Cash Flow
N/A
Beta
0.04
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BACQ Overview
Inflection Point Acquisition Corp. IV does not have any significant business. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to acquire companies in the technology, media, and telecommunications sector, as well as sectors that are being transformed via technology adoption. The company was formerly known as Bleichroeder Acquisition Corp. I and change its name to Inflection Point Acquisition Corp. IV in October 2025. Inflection Point Acquisition Corp. IV was incorporated in 2024 and is based in New York, New York.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BACQ's potential to beat the market
- BACQ doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
BACQ
RankedUnranked of 34
RankedUnranked of 34
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $11.60 | C | |
| $9.98 | C | |
| $10.62 | C |
Be the first to know about important BACQ news, forecast changes, insider trades & much more!
BACQ News
Overview
Due Diligence Score
–
Industry Average (5)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BACQ scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BACQ's short-term liabilities ($3.12M) exceed its short-term assets ($1.33M)
Short-term Liabilities Financials
BACQ's long-term liabilities ($8.75M) exceed its short-term assets ($1.33M)
Long-term Liabilities Financials
BACQ's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
There are 30 more BACQ due diligence checks available for Premium users.
Valuation
BACQ price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
11.36x
Market
43.06x
BACQ price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-33.92x
Industry
-64.39x
BACQ's financial health
Profit margin
Revenue
$0.0
Net Income
$83.7k
Profit Margin
0%
Assets to liabilities
Assets
$261.1M
Liabilities
$11.9M
Debt to equity
-1.13
BACQ's short-term liabilities ($3.12M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BACQ's long-term liabilities ($8.75M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BACQ's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BACQ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$703.8k
Investing
$0.0
Financing
$0.0
BACQ vs Shell Company Stocks
Inflection Point Acquisition IV Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.